Erpicum P, Bonvoisin C, Grosch S, Bovy C, Pinto Coelho T, Detry O, Jouret F, Weekers L, Bouquegneau A
Service de Néphrologie, Dialyse et Transplantation CHU Liège, Belgique.
Groupe Interdisciplinaire de Génoprotéomique Appliquée (GIGA), Unité de Recherche Cardio-Vasculaire, ULiège, Belgique.
Rev Med Liege. 2022 May;77(5-6):338-344.
Renal allograft rejection involves many mechanisms of innate and adaptive immunity, responsible for parenchymal inflammatory lesions that negatively impact the long-term outcomes of the renal allograft. The heterogeneous presentations of rejections in terms of clinical, biological and histological aspects make them difficult to manage in daily clinical practice. Indeed, current therapeutic strategies are disappointing in term of long-term outcomes, including graft survival. In this article, we will discuss the main effector mechanisms of rejection and their histological classification, as well as the existing treatments and those currently under evaluation.
肾移植排斥反应涉及多种先天性和适应性免疫机制,这些机制会导致实质炎症性病变,对肾移植的长期预后产生负面影响。排斥反应在临床、生物学和组织学方面表现各异,这使得在日常临床实践中对其进行管理变得困难。事实上,就长期预后而言,包括移植物存活情况,目前的治疗策略并不理想。在本文中,我们将讨论排斥反应的主要效应机制及其组织学分类,以及现有的治疗方法和目前正在评估的治疗方法。